Positron emission tomography imaging of DMBA/TPA mouse skin multi-step tumorigenesis

Molecular Oncology

Volumn 4, Issue 2, 2010, Pages 119-125

  Ishikawa, Tomo o ^a   Kumar, Indracanti Prem ^a   Machado, Hidevaldo B ^a   Wong, Koon Pong ^a   Kusewitt, Donna ^b   Huang, Sung Cheng ^a   Fischer, Susan M ^b   Herschman, Harvey R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Fluorodeoxyglucose; Glucose metabolism; Molecular imaging; PET; Skin cancer

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; FLUORODEOXYGLUCOSE F 18; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SKIN CANCER; SKIN CARCINOGENESIS; SKIN PAPILLOMA; SQUAMOUS CELL CARCINOMA;

MURINAE;

EID: 77949263619     PISSN: 15747891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molonc.2010.01.005     Document Type: Article

References (23)

1. Abbey C.K., Borowsky A.D., Gregg J.P., Cardiff R.D., and Cherry S.R. Preclinical imaging of mammary intraepithelial neoplasia with positron emission tomography. J. Mammary Gland Biol. Neoplasia 11 2 (2006) 137-149
2. Abbey C.K., Borowsky A.D., McGoldrick E.T., Gregg J.P., Maglione J.E., Cardiff R.D., and Cherry S.R. In vivo positron-emission tomography imaging of progression and transformation in a mouse model of mammary neoplasia. Proc. Natl. Acad. Sci. U.S.A. 101 31 (2004) 11438-11443
3. Abel E.L., Angel J.M., Kiguchi K., and DiGiovanni J. Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat. Protoc. 4 9 (2009) 1350-1362
4. Bensaad K., and Vousden K.H. p53: new roles in metabolism. Trends Cell Biol. 17 6 (2007) 286-291
5. Biaglow J.E., Cerniglia G., Tuttle S., Bakanauskas V., Stevens C., and McKenna G. Effect of oncogene transformation of rat embryo cells on cellular oxygen consumption and glycolysis. Biochem. Biophys. Res. Commun. 235 3 (1997) 739-742
6. Blum R., Jacob-Hirsch J., Amariglio N., Rechavi G., and Kloog Y. Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death. Cancer Res. 65 3 (2005) 999-1006
7. Buerkle A., and Weber W.A. Imaging of tumor glucose utilization with positron emission tomography. Cancer Metastasis Rev. 27 4 (2008) 545-554
8. Cherry S.R. Fundamentals of positron emission tomography and applications in preclinical drug development. J. Clin. Pharmacol. 41 5 (2001) 482-491
9. Frese K.K., and Tuveson D.A. Maximizing mouse cancer models. Nat. Rev. Cancer 7 9 (2007) 645-658
10. Gambhir S.S., Czernin J., Schwimmer J., Silverman D.H., Coleman R.E., and Phelps M.E. A tabulated summary of the FDG PET literature. J. Nucl. Med. 42 5 Suppl. (2001) 1S-93S
11. Gillies R.J., Robey I., and Gatenby R.A. Causes and consequences of increased glucose metabolism of cancers. J. Nucl. Med. 49 Suppl 2 (2008) 24S-42S
12. Hennings H., Glick A.B., Lowry D.T., Krsmanovic L.S., Sly L.M., and Yuspa S.H. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis 14 11 (1993) 2353-2358
13. Herschman H.R. Micro-PET imaging and small animal models of disease. Curr. Opin. Immunol. 15 4 (2003) 378-384
14. Kelloff G.J., Hoffman J.M., Johnson B., Scher H.I., Siegel B.A., Cheng E.Y., Cheson B.D., O'Shaughnessy J., Guyton K.Z., Mankoff D.A., et al. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin. Cancer Res. 11 8 (2005) 2785-2808
15. Kemp C.J. Multistep skin cancer in mice as a model to study the evolution of cancer cells. Semin. Cancer Biol. 15 6 (2005) 460-473
16. Kondoh H., Lleonart M.E., Gil J., Wang J., Degan P., Peters G., Martinez D., Carnero A., and Beach D. Glycolytic enzymes can modulate cellular life span. Cancer Res. 65 1 (2005) 177-185
17. Loening A.M., and Gambhir S.S. AMIDE: a free software tool for multimodality medical image analysis. Mol. Imaging 2 3 (2003) 131-137
18. Ortega A.D., Sanchez-Arago M., Giner-Sanchez D., Sanchez-Cenizo L., Willers I., and Cuezva J.M. Glucose avidity of carcinomas. Cancer Lett. 276 2 (2009) 125-135
19. Phelps M.E. Inaugural article: positron emission tomography provides molecular imaging of biological processes. Proc. Natl. Acad. Sci. U.S.A. 97 16 (2000) 9226-9233
20. Quintanilla M., Brown K., Ramsden M., and Balmain A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322 6074 (1986) 78-80
21. Thomas-Ahner J.M., Wulff B.C., Tober K.L., Kusewitt D.F., Riggenbach J.A., and Oberyszyn T.M. Gender differences in UVB-induced skin carcinogenesis, inflammation, and DNA damage. Cancer Res. 67 7 (2007) 3468-3474
22. Vander Heiden M.G., Cantley L.C., and Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324 5930 (2009) 1029-1033
23. Wakabayashi Y., Mao J.H., Brown K., Girardi M., and Balmain A. Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice. Nature 445 7129 (2007) 761-765